Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-090061
Filing Date
2026-08-04
Accepted
2026-08-04 07:15:53
Documents
2
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2621854-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2621854-1_3seq1.xml 3 1729
2 EXHIBIT 24 tm2621854d1_ex24.htm EX-24 7323
  Complete submission text file 0001104659-26-090061.txt   10682
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address
Carr Molly (Reporting) CIK: 0002147544 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35023 | Film No.: 261235439